ipecac syrup (Rx, OTC)Brand and Other Names:

 
 
 

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

oral syrup

  • 7%
more...

Overdose/Poisoning

15-30 mL PO once; may repeat once with 15 mL if vomiting does not occur within 20-30 min

If vomiting does not occur within 30-45 min after second dose, perform gastric lavage

Give with 3-4 glasses of water

Dosage Forms & Strengths

oral syrup

  • 7%
more...

Overdose/Poisoning

<6-12 months: 5-10 mL PO once with 4-8 ounces of water; give only under medical supervision

1-12 years: 15 mL PO once with 1-2 glasses of water; may repeat once with 15 mL once if vomiting does not occur within 20-30 min

>12 years: As adults; 5-30 mL PO once with 3-4 glasses of water; may repeat once with 15 mL once if vomiting does not occur within 20-30 min

If vomiting does not occur within 30-45 min after second dose, perform gastric lavage

Next

Adverse Effects

Frequency Not Defined

Prolonged vomiting

Aspiration

CNS depression

Mallory-Weiss tear

Delay of other therapy (charcoal/N-acetylcysteine)

Pneumomediastinum

May cause vomiting-induced vagal bradycardia

Previous
Next

Warnings

Contraindications

Lethargy

Absent gag reflex

Coma

Short time between ingestion of poison and charcoal administration/lavage

History of ingestion of substence that causes CNS depression or seizures

Ingestion of caustics, volatile liquids, or sharp objects

Cautions

May not work on empty stomach

Do not confuse ipecac syrup with ipecac fluid extract (14 times stronger)

Not indicated if patient had spontaneous vomiting

Falling out of favor with many poison control centers; may delay gastric lavage if vomiting prolonged

Milk or carbonated beverages may decrease effect

Abuse may occur in patients with bulimia or anorexia nervosa; associated with cardiomyopathies and death in patients with eating disorder

May be cardiotoxic if not vomited and allowed to be absorbed; emetine absorption may result in heart conduction disturbances

Previous
Next

Pregnancy & Lactation

Pregnancy Category: C

Lactation: Unknown if excreted in breast milk; caution advised

Pregnancy Categories

A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA:Information not available.

more...
Previous
Next

Pharmacology

Mechanism of Action

Gastric irritant and stimulates chemoreceptor trigger zone in CNS by alkaloids emetine and cephaeline to produce vomiting

Pharmacokinetics

Effective within 30 min post ingestion

Absorption: Significant when emesis not produced

Previous
Next

Images

Previous
Next

Formulary

FormularyPatient Discounts

To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

Adding plans allows you to:

  • View the formulary and any restrictions for each plan.
  • Manage and view all your plans together – even plans in different states.
  • Compare formulary status to other drugs in the same class.
  • Access your plan list on any device – mobile or desktop.

The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

Tier Description
1 This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
2 This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
3 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
4 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
5 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
6 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
NC NOT COVERED – Drugs that are not covered by the plan.
Code Definition
PA Prior Authorization
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
QL Quantity Limits
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
ST Step Therapy
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
OR Other Restrictions
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Add or Remove Plans
Plans for
Select State:
Non-Medicare PlansMedicare Plans

Select a box to add or remove a plan.

Select a class to view formulary status for similar drugs

Additional Offers
Email to Patient

From:

To:

The recipient will receive more details and instructions to access this offer.

By clicking send, you acknowledge that you have permission to email the recipient with this information.

Email Forms to Patient

From:

To:

The recipient will receive more details and instructions to access this offer.

By clicking send, you acknowledge that you have permission to email the recipient with this information.

Previous
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.